| Veliparib studied in …STUDIED_INderived98 of 98show fewer |
|---|
| → studied in | NCT01012817Phase 1/Phase 2 · active not recruiting Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer · 98 trials list this drug (13 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm,Primary Peritoneal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01585805Phase 2 · active not recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · 98 trials list this drug (13 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01351909Phase 1 · active not recruiting Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer · 98 trials list this drug (13 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366144Phase 1 · active not recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction · 98 trials list this drug (13 active) | — | — | Malignant Neoplasm,Malignant Head and Neck Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00740805Phase 1 · active not recruiting Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma · 98 trials list this drug (13 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · 98 trials list this drug (13 active) | — | — | Lung Adenocarcinoma, Mixed Subtype,Lung Large Cell Carcinoma,Lung Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01434316Phase 1 · active not recruiting Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors · 98 trials list this drug (13 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152982Phase 2/Phase 3 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 98 trials list this drug (13 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03581292Phase 2 · active not recruiting Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations · 98 trials list this drug (13 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642251Phase 1/Phase 2 · completed Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer · 98 trials list this drug (13 active) | — | — | Neuroendocrine Carcinoma,Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289910Phase 2 · active not recruiting Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia · 98 trials list this drug (13 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638546Phase 2 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer · 98 trials list this drug (13 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251874Phase 1 · active not recruiting Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890355Phase 2 · completed FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer · 98 trials list this drug (13 active) | — | — | Pancreatic Neoplasm,Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042379Phase 2 · recruiting I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer · 98 trials list this drug (13 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Early Stage Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595905Phase 2 · completed Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases · 98 trials list this drug (13 active) | — | — | Breast Carcinoma,BRCA Hereditary Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921256Phase 2 · completed Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer · 98 trials list this drug (13 active) | — | — | Malignant Rectal Neoplasm,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · 98 trials list this drug (13 active) | — | — | Acute Lymphoblastic Leukemia,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01489865Phase 1/Phase 2 · completed ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer · 98 trials list this drug (13 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149083Phase 2 · completed Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer · 98 trials list this drug (13 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01818063Phase 2 · completed Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00576654Phase 1 · completed Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery · 98 trials list this drug (13 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · 98 trials list this drug (13 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Myelodysplastic Syndrome,Secondary Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01009788Phase 2 · completed ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02163694Phase 3 · completed A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01205828Phase 2 · terminated ABT-888 and Temozolomide for Liver Cancer · 98 trials list this drug (13 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631733Phase 1 · completed Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors · 98 trials list this drug (13 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02470585Phase 3 · terminated Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 98 trials list this drug (13 active) | — | — | Ovarian Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03061188Phase 1 · completed Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma · 98 trials list this drug (13 active) | — | — | Solid Neoplasm,T-Cell Non-Hodgkin Lymphoma,Aggressive Non-Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01618357Phase 1 · completed Pre-Operative Radiation and Veliparib for Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03044795Phase 2 · withdrawn Response to PARP Inhibitor Predicted by the RAD51 Assay · 98 trials list this drug (13 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827384Phase 2 · completed MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations · 98 trials list this drug (13 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711541Phase 1/Phase 2 · completed Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer · 98 trials list this drug (13 active) | — | — | Head and Neck Squamous Cell Carcinoma,Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03123211no longer available Expanded Access to Veliparib · 98 trials list this drug (13 active) | — | — | Triple-Negative Breast Carcinoma,High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03400306Phase 1 · withdrawn A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer · 98 trials list this drug (13 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506609Phase 2 · completed Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00989651Phase 1 · completed Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · 98 trials list this drug (13 active) | — | — | Ovarian Brenner Tumor,Ovarian Seromucinous Tumor,Primary Peritoneal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01063816Phase 1 · completed A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors · 98 trials list this drug (13 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01123876Phase 1 · completed Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor · 98 trials list this drug (13 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02985658no longer available Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer · 98 trials list this drug (13 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02860819Phase 2 · completed Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer · 98 trials list this drug (13 active) | — | — | Malignant Testicular Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264990Phase 3 · completed Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers · 98 trials list this drug (13 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03227016Phase 1 · unknown Study in Patients With SCLC of Veliparib in Combination With Topotecan · 98 trials list this drug (13 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02032277Phase 3 · completed A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer · 98 trials list this drug (13 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106546Phase 3 · completed Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer · 98 trials list this drug (13 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01576172Phase 2 · completed Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · 98 trials list this drug (13 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412371Phase 1/Phase 2 · terminated A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) · 98 trials list this drug (13 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01908478Phase 1 · completed Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer · 98 trials list this drug (13 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01749397Phase 1 · completed Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer · 98 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02289690Phase 1/Phase 2 · completed Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer · 98 trials list this drug (13 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445522Phase 1 · completed ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer · 98 trials list this drug (13 active) | — | — | Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326702Phase 1/Phase 2 · completed Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors · 98 trials list this drug (13 active) | — | — | Adult Solid Neoplasm,Anaplastic Large Cell Lymphoma,Hairy Cell Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994071Phase 1 · completed A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors · 98 trials list this drug (13 active) | — | — | Primitive Neuroectodermal Tumor,Medulloblastoma,Brain Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02944396Phase 1 · completed Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC) · 98 trials list this drug (13 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01514201Phase 1/Phase 2 · completed Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas · 98 trials list this drug (13 active) | — | — | Anaplastic Astrocytoma,Childhood Mixed Glioma,Giant Cell Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266447Phase 2 · completed Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer · 98 trials list this drug (13 active) | — | — | Cervical Adenocarcinoma,Cervical Squamous Cell Carcinoma,Cervical Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01540565Phase 2 · completed Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 98 trials list this drug (13 active) | — | — | Ovarian Epithelial Tumor,Primary Peritoneal Carcinoma,Ovarian Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01459380Phase 1 · completed Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · 98 trials list this drug (13 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Ovarian Clear Cell Cystadenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281852Phase 1 · completed Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer · 98 trials list this drug (13 active) | — | — | Cervical Adenocarcinoma,Cervical Squamous Cell Carcinoma,Cervical Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01051596Phase 2 · completed A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer · 98 trials list this drug (13 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02305758Phase 2 · completed Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer · 98 trials list this drug (13 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00892736Phase 1 · completed Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy · 98 trials list this drug (13 active) | — | — | Solid Neoplasm,Breast Carcinoma,Primary Peritoneal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00770471Phase 1 · completed ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 98 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00804908Phase 2 · completed A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma · 98 trials list this drug (13 active) | — | — | Malignant Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01113957Phase 2 · completed A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer · 98 trials list this drug (13 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01657799Phase 2 · completed Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer · 98 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02210663Phase 1 · completed A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors · 98 trials list this drug (13 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01145430Phase 1 · completed Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer · 98 trials list this drug (13 active) | — | — | Breast Carcinoma,Primary Peritoneal Carcinoma,Male Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01477489Phase 1 · completed Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00526617Phase 1 · completed A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm,Melanoma,Hepatocellular Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00649207Phase 1 · completed A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases · 98 trials list this drug (13 active) | — | — | Nervous System Neoplasm,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01085422Phase 1 · completed A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer · 98 trials list this drug (13 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199224Phase 1 · completed To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors · 98 trials list this drug (13 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01264432Phase 1 · completed Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer · 98 trials list this drug (13 active) | — | — | Adult Solid Neoplasm,Primary Peritoneal Carcinoma,Ovarian Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01853306Phase 1 · completed A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors · 98 trials list this drug (13 active) | — | — | BRCA Hereditary Breast Carcinoma,High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01589419Phase 1 · completed A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer · 98 trials list this drug (13 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01617928Phase 1 · completed A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors · 98 trials list this drug (13 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009631Phase 1 · completed A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors · 98 trials list this drug (13 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02483104Phase 1 · completed Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer · 98 trials list this drug (13 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03032614Phase 2 · withdrawn Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · 98 trials list this drug (13 active) | — | — | Neuroendocrine Neoplasm,Functioning Pancreatic Neuroendocrine Tumor,Multiple Endocrine Neoplasia Type 1+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01104259Phase 1 · completed Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer · 98 trials list this drug (13 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00553189Phase 1 · completed Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas · 98 trials list this drug (13 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01419548Phase 1 · withdrawn ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems · 98 trials list this drug (13 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306032Phase 2 · completed Phase II ABT-888 With Cyclophosphamide · 98 trials list this drug (13 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01472783Phase 1/Phase 2 · completed Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation · 98 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02033551Phase 1 · completed A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors · 98 trials list this drug (13 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01017640Phase 1 · completed Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors · 98 trials list this drug (13 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01560104Phase 2 · completed A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer · 98 trials list this drug (13 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154426Phase 1 · completed ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors · 98 trials list this drug (13 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01690598Phase 1/Phase 2 · completed Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status · 98 trials list this drug (13 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281150Phase 1 · completed Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors · 98 trials list this drug (13 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00535119Phase 1 · completed Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer · 98 trials list this drug (13 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · 98 trials list this drug (13 active) | — | — | Choroid Plexus Neoplasm,Central Nervous System Medulloepithelioma,Childhood Central Nervous System Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01233505Phase 1 · terminated Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors · 98 trials list this drug (13 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Ovarian Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01282333Phase 1 · terminated Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer · 98 trials list this drug (13 active) | — | — | Malignant Pancreatic Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Gallbladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01193140Phase 2 · completed To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors · 98 trials list this drug (13 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387608Phase 1 · completed ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer · 98 trials list this drug (13 active) | — | — | Adult Solid Neoplasm,Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |